The Application of Drugs and Nano-Therapies Targeting Immune Cells in Hypoxic Inflammation

References

• Mirchandani AS, Jenkins SJ, Bain CC, et al. Hypoxia shapes the immune landscape in lung injury and promotes the persistence of inflammation. Nat Immunol. 2022;23(6):927–939. doi:10.1038/s41590-022-01216-z
   Web of Science ®Google Scholar
• Delprat V, Huart C, Feron O, Soncin F, Michiels C. The impact of macrophages on endothelial cells is potentiated by cycling hypoxia: enhanced tumor inflammation and metastasis. Front Oncol. 2022;12:961753. doi:10.3389/fonc.2022.961753
   Web of Science ®Google Scholar
• Ivashkiv LB. The hypoxia-lactate axis tempers inflammation. Nat Rev Immunol. 2020;20(2):85–86. doi:10.1038/s41577-019-0259-8
   PubMed Web of Science ®Google Scholar
• Peng M, Yin N, Chhangawala S, et al. Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism. Science. 2016;354(6311):481–484. doi:10.1126/science.aaf6284
   PubMed Web of Science ®Google Scholar
• Taylor CT, Colgan SP. Regulation of immunity and inflammation by hypoxia in immunological niches. Nat Rev Immunol. 2017;17(12):774–785. doi:10.1038/nri.2017.103
   PubMed Web of Science ®Google Scholar
• Corcoran SE, O’Neill LA. HIF1α and metabolic reprogramming in inflammation. J Clin Invest. 2016;126(10):3699–3707. doi:10.1172/JCI84431
   PubMed Web of Science ®Google Scholar
• Eltzschig HK, Carmeliet P, Schwartz RS. Hypoxia and inflammation. N Engl J Med. 2011;364(7):656–665. doi:10.1056/NEJMra0910283
   PubMed Web of Science ®Google Scholar
• Colgan SP, Campbell EL, Kominsky DJ. Hypoxia and Mucosal Inflammation. Annu Rev Pathol. 2016;11(1):77–100. doi:10.1146/annurev-pathol-012615-044231
   PubMedGoogle Scholar
• Campbell EL, Bruyninckx WJ, Kelly CJ, et al. Transmigrating neutrophils shape the mucosal microenvironment through localized oxygen depletion to influence resolution of inflammation. Immunity. 2014;40(1):66–77. doi:10.1016/j.immuni.2013.11.020
   PubMed Web of Science ®Google Scholar
• Tu C, Lu H, Zhou T, et al. Promoting the healing of infected diabetic wound by an anti-bacterial and nano-enzyme-containing hydrogel with inflammation-suppressing, ROS-scavenging, oxygen and nitric oxide-generating properties. Biomaterials. 2022;286:121597. doi:10.1016/j.biomaterials.2022.121597
   PubMed Web of Science ®Google Scholar
• Lin Y, Xue K, Li Q, et al. Cyclin-dependent kinase 7 promotes Th17/Th1 cell differentiation in psoriasis by modulating glycolytic metabolism. J Invest Dermatol. 2021;141(11):2656–2667.e2611. doi:10.1016/j.jid.2021.04.018
   PubMed Web of Science ®Google Scholar
• Han X, Ju LS, Irudayaraj J. Oxygenated wound dressings for hypoxia mitigation and enhanced wound healing. Mol Pharm. 2023;20(7):3338–3355. doi:10.1021/acs.molpharmaceut.3c00352
   Google Scholar
• Netea MG, Joosten LA, Latz E, et al. Trained immunity: a program of innate immune memory in health and disease. Science. 2016;352(6284):aaf1098. doi:10.1126/science.aaf1098
   PubMed Web of Science ®Google Scholar
• Tacke F, Zimmermann HW. Macrophage heterogeneity in liver injury and fibrosis. J Hepatol. 2014;60(5):1090–1096. doi:10.1016/j.jhep.2013.12.025
   PubMed Web of Science ®Google Scholar
• Arrese M, Cabrera D, Kalergis AM, et al. Innate immunity and inflammation in NAFLD/NASH. Dig Dis Sci. 2016;61(5):1294–1303. doi:10.1007/s10620-016-4049-x
   PubMed Web of Science ®Google Scholar
• Li Y, Liang Q, Zhou L, et al. An ROS-responsive artesunate prodrug nanosystem co-delivers dexamethasone for rheumatoid arthritis treatment through the HIF-1α/NF-κB cascade regulation of ROS scavenging and macrophage repolarization. Acta Biomater. 2022;152:406–424. doi:10.1016/j.actbio.2022.08.054
   PubMed Web of Science ®Google Scholar
• Doi K, Murata K, Ito S, et al. Role of lysine-specific demethylase 1 in Metabolically integrating osteoclast differentiation and inflammatory bone resorption through hypoxia-inducible factor 1α and E2F1. Arthritis Rheumatol. 2022;74(6):948–960. doi:10.1002/art.42074
   Web of Science ®Google Scholar
• Zhang J, Zhang Q, Lou Y, et al. Hypoxia-inducible factor-1α/interleukin-1β signaling enhances hepatoma epithelial-mesenchymal transition through macrophages in a hypoxic-inflammatory microenvironment. Hepatology. 2018;67(5):1872–1889. doi:10.1002/hep.29681
   PubMed Web of Science ®Google Scholar
• Chen F, Chen J, Yang L, et al. Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells. Nat Cell Biol. 2019;21(4):498–510. doi:10.1038/s41556-019-0299-0
   PubMed Web of Science ®Google Scholar
• Karshovska E, Wei Y, Subramanian P, et al. HIF-1α (Hypoxia-Inducible Factor-1α) promotes macrophage necroptosis by regulating miR-210 and miR-383. Arterioscler Thromb Vasc Biol. 2020;40(3):583–596. doi:10.1161/ATVBAHA.119.313290
   PubMed Web of Science ®Google Scholar
• Zhong WJ, Liu T, Yang HH, et al. TREM-1 governs NLRP3 inflammasome activation of macrophages by firing up glycolysis in acute lung injury. Int J Biol Sci. 2023;19(1):242–257. doi:10.7150/ijbs.77304
   PubMed Web of Science ®Google Scholar
• Li W, Cao T, Luo C, et al. Crosstalk between ER stress, NLRP3 inflammasome, and inflammation. Appl Microbiol Biotechnol. 2020;104(14):6129–6140. doi:10.1007/s00253-020-10614-y
   PubMed Web of Science ®Google Scholar
• Chen MH, Wang YH, Sun BJ, et al. HIF-1α activator DMOG inhibits alveolar bone resorption in murine periodontitis by regulating macrophage polarization. Int Immunopharmacol. 2021;99:107901. doi:10.1016/j.intimp.2021.107901
   Web of Science ®Google Scholar
• Acosta-Iborra B, Elorza A, Olazabal IM, et al. Macrophage oxygen sensing modulates antigen presentation and phagocytic functions involving IFN-gamma production through the HIF-1 alpha transcription factor. J Immunol. 2009;182(5):3155–3164. doi:10.4049/jimmunol.0801710
   PubMed Web of Science ®Google Scholar
• Semba H, Takeda N, Isagawa T, et al. HIF-1α-PDK1 axis-induced active glycolysis plays an essential role in macrophage migratory capacity. Nat Commun. 2016;7(1):11635. doi:10.1038/ncomms11635
   PubMed Web of Science ®Google Scholar
• Colegio OR, Chu NQ, Szabo AL, et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature. 2014;513(7519):559–563. doi:10.1038/nature13490
   PubMed Web of Science ®Google Scholar
• Liu N, Luo J, Kuang D, et al. Lactate inhibits ATP6V0d2 expression in tumor-associated macrophages to promote HIF-2α-mediated tumor progression. J Clin Invest. 2019;129(2):631–646. doi:10.1172/JCI123027
   PubMed Web of Science ®Google Scholar
• Choe SS, Shin KC, Ka S, et al. Macrophage HIF-2α ameliorates adipose tissue inflammation and insulin resistance in obesity. Diabetes. 2014;63(10):3359–3371. doi:10.2337/db13-1965
   PubMed Web of Science ®Google Scholar
• Li M, Sun X, Zhao J, et al. CCL5 deficiency promotes liver repair by improving inflammation resolution and liver regeneration through M2 macrophage polarization. Cell Mol Immunol. 2020;17(7):753–764. doi:10.1038/s41423-019-0279-0
   PubMed Web of Science ®Google Scholar
• Lodge KM, Cowburn AS, Li W, Condliffe AM. The impact of hypoxia on neutrophil degranulation and consequences for the host. Int J Mol Sci. 2020;21(4):1183. doi:10.3390/ijms21041183
   PubMed Web of Science ®Google Scholar
• Triner D, Xue X, Schwartz AJ, et al. Epithelial hypoxia-inducible factor 2α facilitates the progression of colon tumors through recruiting neutrophils. Mol Cell Biol. 2017;37(5). doi:10.1128/MCB.00481-16
   Web of Science ®Google Scholar
• Curi R, Levada-Pires AC, Silva EBD, et al. The critical role of cell metabolism for essential neutrophil functions. Cell Physiol Biochem. 2020;54(4):629–647.
   Google Scholar
• Willson JA, Arienti S, Sadiku P, et al. Neutrophil HIF-1α stabilization is augmented by mitochondrial ROS produced via the glycerol 3-phosphate shuttle. Blood. 2022;139(2):281–286. doi:10.1182/blood.2021011010
   Web of Science ®Google Scholar
• Harris AJ, Mirchandani AS, Lynch RW, et al. IL4Rα signaling abrogates hypoxic neutrophil survival and limits acute lung injury responses in vivo. Am J Respir Crit Care Med. 2019;200(2):235–246. doi:10.1164/rccm.201808-1599OC
   Web of Science ®Google Scholar
• Fresneda Alarcon M, McLaren Z, Wright HL. Neutrophils in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus: same foe different M.O. Front Immunol. 2021;12:649693. doi:10.3389/fimmu.2021.649693
   PubMed Web of Science ®Google Scholar
• Tan BH, Meinken C, Bastian M, et al. Macrophages acquire neutrophil granules for antimicrobial activity against intracellular pathogens. J Immunol. 2006;177(3):1864–1871. doi:10.4049/jimmunol.177.3.1864
   PubMed Web of Science ®Google Scholar
• Hajdamowicz NH, Hull RC, Foster SJ, Condliffe AM. The impact of hypoxia on the host-pathogen interaction between neutrophils and Staphylococcus aureus. Int J Mol Sci. 2019;20(22):5561. doi:10.3390/ijms20225561
   Web of Science ®Google Scholar
• Alfaidi M, Wilson H, Daigneault M, et al. Neutrophil elastase promotes interleukin-1β secretion from human coronary endothelium. J Biol Chem. 2015;290(40):24067–24078. doi:10.1074/jbc.M115.659029
   PubMed Web of Science ®Google Scholar
• Jing H, Chen X, Zhang S, et al. Neutrophil extracellular traps (NETs): the role of inflammation and coagulation in COVID-19. Am J Transl Res. 2021;13(8):8575–8588.
   PubMed Web of Science ®Google Scholar
• Tang YY, Wang DC, Wang YQ, Huang AF, Xu WD. Emerging role of hypoxia-inducible factor-1α in inflammatory autoimmune diseases: a comprehensive review. Front Immunol. 2022;13:1073971. doi:10.3389/fimmu.2022.1073971
   Web of Science ®Google Scholar
• McInturff AM, Cody MJ, Elliott EA, et al. Mammalian target of rapamycin regulates neutrophil extracellular trap formation via induction of hypoxia-inducible factor 1 α. Blood. 2012;120(15):3118–3125. doi:10.1182/blood-2012-01-405993
   PubMed Web of Science ®Google Scholar
• Flück K, Breves G, Fandrey J, Winning S. Hypoxia-inducible factor 1 in dendritic cells is crucial for the activation of protective regulatory T cells in murine colitis. Mucosal Immunol. 2016;9(2):379–390. doi:10.1038/mi.2015.67
   PubMed Web of Science ®Google Scholar
• Filippi I, Morena E, Aldinucci C, et al. Short-term hypoxia enhances the migratory capability of dendritic cell through HIF-1α and PI3K/Akt pathway. J Cell Physiol. 2014;229(12):2067–2076. doi:10.1002/jcp.24666
   Web of Science ®Google Scholar
• Qu X, Yang MX, Kong BH, et al. Hypoxia inhibits the migratory capacity of human monocyte-derived dendritic cells. Immunol Cell Biol. 2005;83(6):668–673. doi:10.1111/j.1440-1711.2005.01383.x
   PubMed Web of Science ®Google Scholar
• Liu J, Zhang X, Chen K, et al. CCR7 chemokine receptor-inducible lnc-Dpf3 restrains dendritic cell migration by inhibiting HIF-1α-mediated glycolysis. Immunity. 2019;50(3):600–615.e615. doi:10.1016/j.immuni.2019.01.021
   PubMed Web of Science ®Google Scholar
• Paardekooper LM, Bendix MB, Ottria A, et al. Hypoxia potentiates monocyte-derived dendritic cells for release of tumor necrosis factor α via MAP3K8. Biosci Rep. 2018;38(6). doi:10.1042/BSR20182019
   Google Scholar
• Fliesser M, Wallstein M, Kurzai O, Einsele H, Löffler J. Hypoxia attenuates anti-Aspergillus fumigatus immune responses initiated by human dendritic cells. Mycoses. 2016;59(8):503–508. doi:10.1111/myc.12498
   Web of Science ®Google Scholar
• Wang Q, Liu C, Zhu F, et al. Reoxygenation of hypoxia-differentiated dentritic cells induces Th1 and Th17 cell differentiation. Mol Immunol. 2010;47(4):922–931. doi:10.1016/j.molimm.2009.09.038
   Web of Science ®Google Scholar
• Pierobon D, Bosco MC, Blengio F, et al. Chronic hypoxia reprograms human immature dendritic cells by inducing a proinflammatory phenotype and TREM-1 expression. Eur J Immunol. 2013;43(4):949–966. doi:10.1002/eji.201242709
   Web of Science ®Google Scholar
• Winning S, Fandrey J. Dendritic cells under hypoxia: how oxygen shortage affects the linkage between innate and adaptive immunity. J Immunol Res. 2016;2016:5134329. doi:10.1155/2016/5134329
   Web of Science ®Google Scholar
• Elia AR, Cappello P, Puppo M, et al. Human dendritic cells differentiated in hypoxia down-modulate antigen uptake and change their chemokine expression profile. J Leukoc Biol. 2008;84(6):1472–1482. doi:10.1189/jlb.0208082
   PubMed Web of Science ®Google Scholar
• Teng R, Wang Y, Lv N, et al. Hypoxia impairs NK cell cytotoxicity through SHP-1-mediated attenuation of STAT3 and ERK signaling pathways. J Immunol Res. 2020;2020:4598476. doi:10.1155/2020/4598476
   Web of Science ®Google Scholar
• Pelletier A, Nelius E, Fan Z, et al. Resting natural killer cell homeostasis relies on tryptophan/NAD(+) metabolism and HIF-1α. EMBO Rep. 2023;24(6):e56156. doi:10.15252/embr.202256156
   Web of Science ®Google Scholar
• Maurus CF, Schmidt D, Schneider MK, et al. Hypoxia and reoxygenation do not upregulate adhesion molecules and natural killer cell adhesion on human endothelial cells in vitro. Eur J Cardiothorac Surg. 2003;23(6):976–983; discussion 983. doi:10.1016/S1010-7940(03)00146-5
   Web of Science ®Google Scholar
• Maurus CF, Schneider MK, Schmidt D, Zünd G, Seebach JD. Activation of human microvascular endothelial cells with TNF-alpha and hypoxia/reoxygenation enhances NK-cell adhesion, but not NK-Cytotoxicity. Transplantation. 2006;81(8):1204–1211. doi:10.1097/01.tp.0000205175.53938.bd
   Web of Science ®Google Scholar
• Pastwińska J, Walczak-Drzewiecka A, Łukasiak M, Ratajewski M, Dastych J. Hypoxia regulates human mast cell adhesion to fibronectin via the PI3K/AKT signaling pathway. Cell Adh Migr. 2020;14(1):106–117. doi:10.1080/19336918.2020.1764690
   PubMed Web of Science ®Google Scholar
• Wang X, Lin L, Chai X, et al. Hypoxic mast cells accelerate the proliferation, collagen accumulation and phenotypic alteration of human lung fibroblasts. Int J Mol Med. 2020;45(1):175–185. doi:10.3892/ijmm.2019.4400
   Web of Science ®Google Scholar
• Pastwińska J, Walczak-Drzewiecka A, Kozłowska E, et al. Hypoxia modulates human mast cell adhesion to hyaluronic acid. Immunol Res. 2022;70(2):152–160. doi:10.1007/s12026-021-09228-x
   Web of Science ®Google Scholar
• Gray KJ, Gibbs JE. Adaptive immunity, chronic inflammation and the clock. Semin Immunopathol. 2022;44(2):209–224. doi:10.1007/s00281-022-00919-7
   PubMed Web of Science ®Google Scholar
• Wolf D, Ley K. Immunity and inflammation in atherosclerosis. Circ Res. 2019;124(2):315–327. doi:10.1161/CIRCRESAHA.118.313591
   PubMed Web of Science ®Google Scholar
• Noman MZ, Desantis G, Janji B, et al. PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation. J Exp Med. 2014;211(5):781–790. doi:10.1084/jem.20131916
   PubMed Web of Science ®Google Scholar
• Palazon A, Tyrakis PA, Macias D, et al. An HIF-1α/VEGF-A axis in cytotoxic T cells regulates tumor progression. Cancer Cell. 2017;32(5):669–683.e665. doi:10.1016/j.ccell.2017.10.003
   PubMed Web of Science ®Google Scholar
• Ning F, Takeda K, Schedel M, et al. Hypoxia enhances CD8(+) T(C)2 cell-dependent airway hyperresponsiveness and inflammation through hypoxia-inducible factor 1α. J Allergy Clin Immunol. 2019;143(6):2026–2037.e2027. doi:10.1016/j.jaci.2018.11.049
   Web of Science ®Google Scholar
• Finlay DK. mTORC1 regulates CD8+ T-cell glucose metabolism and function independently of PI3K and PKB. Biochem Soc Trans. 2013;41(2):681–686. doi:10.1042/BST20120359
   PubMedGoogle Scholar
• Zhou L, Chu C, Teng F, et al. Innate lymphoid cells support regulatory T cells in the intestine through interleukin-2. Nature. 2019;568(7752):405–409. doi:10.1038/s41586-019-1082-x
   PubMed Web of Science ®Google Scholar
• Cho SH, Raybuck AL, Blagih J, et al. Hypoxia-inducible factors in CD4(+) T cells promote metabolism, switch cytokine secretion, and T cell help in humoral immunity. Proc Natl Acad Sci U S A. 2019;116(18):8975–8984. doi:10.1073/pnas.1811702116
   PubMed Web of Science ®Google Scholar
• Arias C, Sepúlveda P, Castillo RL, Salazar LA. Relationship between hypoxic and immune pathways activation in the progression of neuroinflammation: role of HIF-1α and Th17 cells. Int J Mol Sci. 2023;24(4):3073. doi:10.3390/ijms24043073
   Web of Science ®Google Scholar
• Clambey ET, McNamee EN, Westrich JA, et al. Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa. Proc Natl Acad Sci U S A. 2012;109(41):E2784–E2793. doi:10.1073/pnas.1202366109
   PubMed Web of Science ®Google Scholar
• Hsu TS, Lai MZ. Hypoxia-inducible factor 1α plays a predominantly negative role in regulatory T cell functions. J Leukoc Biol. 2018;104(5):911–918. doi:10.1002/JLB.MR1217-481R
   PubMed Web of Science ®Google Scholar
• Lee JH, Elly C, Park Y, Liu YC. E3 ubiquitin ligase VHL regulates hypoxia-inducible factor-1α to maintain regulatory T cell stability and suppressive capacity. Immunity. 2015;42(6):1062–1074. doi:10.1016/j.immuni.2015.05.016
   PubMed Web of Science ®Google Scholar
• Miska J, Lee-Chang C, Rashidi A, et al. HIF-1α is a metabolic switch between glycolytic-driven migration and oxidative phosphorylation-driven immunosuppression of tregs in glioblastoma. Cell Rep. 2019;27(1):226–237.e224. doi:10.1016/j.celrep.2019.03.029
   PubMed Web of Science ®Google Scholar
• Noack M, Miossec P. Th17 and regulatory T cell balance in autoimmune and inflammatory diseases. Autoimmun Rev. 2014;13(6):668–677. doi:10.1016/j.autrev.2013.12.004
   PubMed Web of Science ®Google Scholar
• Dang EV, Barbi J, Yang HY, et al. Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell. 2011;146(5):772–784. doi:10.1016/j.cell.2011.07.033
   PubMed Web of Science ®Google Scholar
• Harnanik T, Soeroso J, Suryokusumo MG, Juliandhy T. Effects of hyperbaric oxygen on T helper 17/regulatory T polarization in antigen and collagen-induced arthritis: hypoxia-inducible factor-1α as a target. Oman Med J. 2020;35(1):e90. doi:10.5001/omj.2020.08
   Google Scholar
• Jellusova J, Cato MH, Apgar JR, et al. Gsk3 is a metabolic checkpoint regulator in B cells. Nat Immunol. 2017;18(3):303–312. doi:10.1038/ni.3664
   PubMed Web of Science ®Google Scholar
• Abbott RK, Thayer M, Labuda J, et al. Germinal center hypoxia potentiates immunoglobulin class switch recombination. J Immunol. 2016;197(10):4014–4020. doi:10.4049/jimmunol.1601401
   Web of Science ®Google Scholar
• Fan C, Li J, Li Y, et al. Hypoxia-inducible factor-1α regulates the interleukin-6 production by B cells in rheumatoid arthritis. Clin Transl Immunology. 2023;12(5):e1447. doi:10.1002/cti2.1447
   Web of Science ®Google Scholar
• Meng X, Grötsch B, Luo Y, et al. Hypoxia-inducible factor-1α is a critical transcription factor for IL-10-producing B cells in autoimmune disease. Nat Commun. 2018;9(1):251. doi:10.1038/s41467-017-02683-x
   PubMedGoogle Scholar
• Zhu Y, Zhang X, Xie S, et al. Oxidative phosphorylation regulates interleukin-10 production in regulatory B cells via the extracellular signal-related kinase pathway. Immunology. 2022;167(4):576–589. doi:10.1111/imm.13554
   Web of Science ®Google Scholar
• Jang JW, Thuy PX, Lee JW, Moon EY. CXCR4 promotes B cell viability by the cooperation of nuclear factor (erythroid-derived 2)-like 2 and hypoxia-inducible factor-1α under hypoxic conditions. Cell Death Dis. 2021;12(4):330. doi:10.1038/s41419-021-03615-w
   Web of Science ®Google Scholar
• Lee KE, Spata M, Maduka R, Vonderheide RH, Simon MC. Hif1α deletion limits tissue regeneration via aberrant B cell accumulation in experimental pancreatitis. Cell Rep. 2018;23(12):3457–3464. doi:10.1016/j.celrep.2018.05.071
   Web of Science ®Google Scholar
• Wang X, Cui L, Ji X. Cognitive impairment caused by hypoxia: from clinical evidences to molecular mechanisms. Metab Brain Dis. 2022;37(1):51–66. doi:10.1007/s11011-021-00796-3
   PubMed Web of Science ®Google Scholar
• Taylor CT, Kent BD, Crinion SJ, McNicholas WT, Ryan S. Human adipocytes are highly sensitive to intermittent hypoxia induced NF-kappaB activity and subsequent inflammatory gene expression. Biochem Biophys Res Commun. 2014;447(4):660–665. doi:10.1016/j.bbrc.2014.04.062
   PubMed Web of Science ®Google Scholar
• Korbecki J, Simińska D, Gąssowska-Dobrowolska M, et al. Chronic and cycling hypoxia: drivers of cancer chronic inflammation through HIF-1 and NF-κB activation: a review of the molecular mechanisms. Int J Mol Sci. 2021;22(19):10701. doi:10.3390/ijms221910701
   PubMed Web of Science ®Google Scholar
• Delprat V, Tellier C, Demazy C, et al. Cycling hypoxia promotes a pro-inflammatory phenotype in macrophages via JNK/p65 signaling pathway. Sci Rep. 2020;10(1):882. doi:10.1038/s41598-020-57677-5
   PubMed Web of Science ®Google Scholar
• Wei Y, Giunta S, Xia S. Hypoxia in aging and aging-related diseases: mechanism and therapeutic strategies. Int J Mol Sci. 2022;23(15):8165.
   Web of Science ®Google Scholar
• González-Muniesa P, Garcia-Gerique L, Quintero P, et al. Effects of hyperoxia on oxygen-related inflammation with a focus on obesity. Oxid Med Cell Longev. 2015;2015:8957827. doi:10.1155/2016/8957827
   PubMedGoogle Scholar
• Le Lay S, Simard G, Martinez MC, Andriantsitohaina R. Oxidative stress and metabolic pathologies: from an adipocentric point of view. Oxid Med Cell Longev. 2014;2014:908539. doi:10.1155/2014/908539
   PubMed Web of Science ®Google Scholar
• Trayhurn P. Hypoxia and adipose tissue function and dysfunction in obesity. Physiol Rev. 2013;93(1):1–21. doi:10.1152/physrev.00017.2012
   PubMed Web of Science ®Google Scholar
• Wood IS, de Heredia FP, Wang B, Trayhurn P. Cellular hypoxia and adipose tissue dysfunction in obesity. Proc Nutr Soc. 2009;68(4):370–377. doi:10.1017/S0029665109990206
   PubMed Web of Science ®Google Scholar
• He Q, Gao Z, Yin J, et al. Regulation of HIF-1{alpha} activity in adipose tissue by obesity-associated factors: adipogenesis, insulin, and hypoxia. Am J Physiol Endocrinol Metab. 2011;300(5):E877–E885. doi:10.1152/ajpendo.00626.2010
   PubMed Web of Science ®Google Scholar
• Zhao M, Wang S, Zuo A, et al. HIF-1α/JMJD1A signaling regulates inflammation and oxidative stress following hyperglycemia and hypoxia-induced vascular cell injury. Cell Mol Biol Lett. 2021;26(1):40. doi:10.1186/s11658-021-00283-8
   Web of Science ®Google Scholar
• Escobar-Morreale HF, Martínez-García M, Montes-Nieto R, et al. Effects of glucose ingestion on circulating inflammatory mediators: influence of sex and weight excess. Clin Nutr. 2017;36(2):522–529. doi:10.1016/j.clnu.2016.01.015
   Web of Science ®Google Scholar
• Zhuang H, Lv Q, Zhong C, et al. Tiliroside ameliorates ulcerative colitis by restoring the M1/M2 macrophage balance via the HIF-1α/glycolysis pathway. Front Immunol. 2021;12:649463. doi:10.3389/fimmu.2021.649463
   Web of Science ®Google Scholar
• Torretta S, Scagliola A, Ricci L, et al. D-mannose suppresses macrophage IL-1β production. Nat Commun. 2020;11(1):6343. doi:10.1038/s41467-020-20164-6
   Web of Science ®Google Scholar
• Lu S, Tian Y, Luo Y, et al. Iminostilbene, a novel small-molecule modulator of PKM2, suppresses macrophage inflammation in myocardial ischemia–reperfusion injury. J Adv Res. 2021;29:83–94. doi:10.1016/j.jare.2020.09.001
   Web of Science ®Google Scholar
• Liu QY, Zhuang Y, Song XR, et al. Tanshinone IIA prevents LPS-induced inflammatory responses in mice via inactivation of succinate dehydrogenase in macrophages. Acta Pharmacol Sin. 2021;42(6):987–997. doi:10.1038/s41401-020-00535-x
   Web of Science ®Google Scholar
• Chen Q, Shao X, He Y, et al. Norisoboldine attenuates sepsis-induced acute lung injury by modulating macrophage polarization via PKM2/HIF-1α/PGC-1α pathway. Biol Pharm Bull. 2021;44(10):1536–1547. doi:10.1248/bpb.b21-00457
   Web of Science ®Google Scholar
• Deng H, Wu L, Liu M, et al. Bone marrow mesenchymal stem cell-derived exosomes attenuate LPS-induced ARDS by modulating macrophage polarization through inhibiting glycolysis in macrophages. Shock. 2020;54(6):828–843. doi:10.1097/SHK.0000000000001549
   PubMed Web of Science ®Google Scholar
• Pei L, Le Y, Chen H, et al. Cynaroside prevents macrophage polarization into pro-inflammatory phenotype and alleviates cecal ligation and puncture-induced liver injury by targeting PKM2/HIF-1α axis. Fitoterapia. 2021;152:104922. doi:10.1016/j.fitote.2021.104922
   PubMed Web of Science ®Google Scholar
• Ouyang S, Yao YH, Zhang ZM, Liu JS, Xiang H. Curcumin inhibits hypoxia inducible factor-1α-induced inflammation and apoptosis in macrophages through an ERK dependent pathway. Eur Rev Med Pharmacol Sci. 2019;23(4):1816–1825. doi:10.26355/eurrev_201902_17145
   PubMed Web of Science ®Google Scholar
• Sun X, Ma L, Li X, et al. Ferulic acid alleviates retinal neovascularization by modulating microglia/macrophage polarization through the ROS/NF-κB axis. Front Immunol. 2022;13:976729. doi:10.3389/fimmu.2022.976729
   Web of Science ®Google Scholar
• Tang TT, Lv LL, Pan MM, et al. Hydroxychloroquine attenuates renal ischemia/reperfusion injury by inhibiting cathepsin mediated NLRP3 inflammasome activation. Cell Death Dis. 2018;9(3):351. doi:10.1038/s41419-018-0378-3
   PubMed Web of Science ®Google Scholar
• Lu H, Lin J, Xu C, et al. Cyclosporine modulates neutrophil functions via the SIRT6-HIF-1α-glycolysis axis to alleviate severe ulcerative colitis. Clin Transl Med. 2021;11(2):e334. doi:10.1002/ctm2.334
   PubMed Web of Science ®Google Scholar
• Miao AF, Liang JX, Yao L, Han JL, Zhou LJ. Hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat (FG-4592) protects against renal ischemia/reperfusion injury by inhibiting inflammation. Ren Fail. 2021;43(1):803–810. doi:10.1080/0886022X.2021.1915801
   PubMed Web of Science ®Google Scholar
• Ngamsri KC, Fabian F, Fuhr A, et al. Sevoflurane exerts protective effects in murine peritonitis-induced sepsis via hypoxia-inducible factor 1α/adenosine A2B receptor signaling. Anesthesiology. 2021;135(1):136–150. doi:10.1097/ALN.0000000000003788
   Web of Science ®Google Scholar
• Burczyk G, Cichon I, Kolaczkowska E. Itaconate suppresses formation of Neutrophil Extracellular Traps (NETs): involvement of Hypoxia-Inducible Factor 1α (Hif-1α) and Heme Oxygenase (HO-1). Front Immunol. 2022;13:864638. doi:10.3389/fimmu.2022.864638
   Web of Science ®Google Scholar
• Kong L, Ma Y, Wang Z, et al. Inhibition of hypoxia inducible factor 1 by YC-1 attenuates tissue plasminogen activator induced hemorrhagic transformation by suppressing HMGB1/TLR4/NF-κB mediated neutrophil infiltration in thromboembolic stroke rats. Int Immunopharmacol. 2021;94:107507. doi:10.1016/j.intimp.2021.107507
   Web of Science ®Google Scholar
• Atzeni F, Benucci M, Sallì S, et al. Different effects of biological drugs in rheumatoid arthritis. Autoimmun Rev. 2013;12(5):575–579. doi:10.1016/j.autrev.2012.10.020
   PubMed Web of Science ®Google Scholar
• Solt LA, Kumar N, Nuhant P, et al. Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand. Nature. 2011;472(7344):491–494. doi:10.1038/nature10075
   PubMed Web of Science ®Google Scholar
• Yao Y, Wang L, Zhou J, Zhang X. HIF-1α inhibitor echinomycin reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect. J Transl Med. 2017;15(1):28. doi:10.1186/s12967-017-1132-9
   Google Scholar
• Huang J, Li Z, Hu Y, et al. Melatonin, an endogenous hormone, modulates Th17 cells via the reactive-oxygen species/TXNIP/HIF-1α axis to alleviate autoimmune uveitis. J Neuroinflammation. 2022;19(1):124. doi:10.1186/s12974-022-02477-z
   Web of Science ®Google Scholar
• Miossec P. IL-17 and Th17 cells in human inflammatory diseases. Microbes Infect. 2009;11(5):625–630. doi:10.1016/j.micinf.2009.04.003
   PubMed Web of Science ®Google Scholar
• Kim J, Kim HY, Song SY, et al. Synergistic oxygen generation and reactive oxygen species scavenging by manganese ferrite/ceria co-decorated nanoparticles for rheumatoid arthritis treatment. ACS Nano. 2019;13(3):3206–3217. doi:10.1021/acsnano.8b08785
   PubMed Web of Science ®Google Scholar
• Cheng YQ, Yue YX, Cao HM, et al. Coassembly of hypoxia-sensitive macrocyclic amphiphiles and extracellular vesicles for targeted kidney injury imaging and therapy. J Nanobiotechnology. 2021;19(1):451. doi:10.1186/s12951-021-01192-w
   PubMed Web of Science ®Google Scholar
• Liu ZJ, Ran YY, Qie SY, et al. Melatonin protects against ischemic stroke by modulating microglia/macrophage polarization toward anti-inflammatory phenotype through STAT3 pathway. CNS Neurosci Ther. 2019;25(12):1353–1362. doi:10.1111/cns.13261
   PubMed Web of Science ®Google Scholar
• Cai M, Sun S, Wang J, et al. Sevoflurane preconditioning protects experimental ischemic stroke by enhancing anti-inflammatory microglia/macrophages phenotype polarization through GSK-3β/Nrf2 pathway. CNS Neurosci Ther. 2021;27(11):1348–1365. doi:10.1111/cns.13715
   Web of Science ®Google Scholar
• Liu Z, Meng Y, Miao Y, et al. Propofol ameliorates renal ischemia/reperfusion injury by enhancing macrophage M2 polarization through PPARγ/STAT3 signaling. Aging. 2021;13(11):15511–15522. doi:10.18632/aging.203107
   Google Scholar
• Lorenz G, Darisipudi MN, Anders HJ. Canonical and non-canonical effects of the NLRP3 inflammasome in kidney inflammation and fibrosis. Nephrol Dial Transplant. 2014;29(1):41–48. doi:10.1093/ndt/gft332
   PubMed Web of Science ®Google Scholar
• Anders HJ. Of inflammasomes and alarmins: IL-1β and IL-1α in kidney disease. J Am Soc Nephrol. 2016;27(9):2564–2575. doi:10.1681/ASN.2016020177
   PubMed Web of Science ®Google Scholar
• Ryan DG, O’Neill LAJ. Krebs cycle reborn in macrophage immunometabolism. Annu Rev Immunol. 2020;38(1):289–313. doi:10.1146/annurev-immunol-081619-104850
   Google Scholar
• Santocki M, Kolaczkowska E. On Neutrophil Extracellular Trap (NET) removal: what we know thus far and why so little. Cells. 2020;9(9):2079. doi:10.3390/cells9092079
   Web of Science ®Google Scholar
• Seif F, Khoshmirsafa M, Aazami H, et al. The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells. Cell Commun Signal. 2017;15(1):23. doi:10.1186/s12964-017-0177-y
   PubMed Web of Science ®Google Scholar
• Tsiogka A, Kyriazopoulou M, Kontochristopoulos G, et al. The JAK/STAT pathway and its selective inhibition in the treatment of atopic dermatitis: a systematic review. J Clin Med. 2022;11(15):4431. doi:10.3390/jcm11154431
   PubMed Web of Science ®Google Scholar
• Patil PS, Fountas-Davis N, Huang H, et al. Fluorinated methacrylamide chitosan hydrogels enhance collagen synthesis in wound healing through increased oxygen availability. Acta Biomater. 2016;36:164–174. doi:10.1016/j.actbio.2016.03.022
   PubMed Web of Science ®Google Scholar
• Patil PS, Mansouri M, Leipzig ND. Fluorinated chitosan microgels to overcome internal oxygen transport deficiencies in microtissue culture systems. Adv Biosyst. 2020;4(8):e1900250. doi:10.1002/adbi.201900250
   Web of Science ®Google Scholar
• Yang Z, Chen H, Yang P, et al. Nano-oxygenated hydrogels for locally and permeably hypoxia relieving to heal chronic wounds. Biomaterials. 2022;282:121401. doi:10.1016/j.biomaterials.2022.121401
   PubMed Web of Science ®Google Scholar
• Lee YH, Lin SJ. Chitosan/PVA hetero-composite hydrogel containing antimicrobials, perfluorocarbon nanoemulsions, and growth factor-loaded nanoparticles as a multifunctional dressing for diabetic wound healing: synthesis, characterization, and in vitro/in vivo evaluation. Pharmaceutics. 2022;14(3). doi:10.3390/pharmaceutics14030537
   Web of Science ®Google Scholar
• Guo J, Agola JO, Serda R, et al. Biomimetic rebuilding of multifunctional red blood cells: modular design using functional components. ACS Nano. 2020;14(7):7847–7859. doi:10.1021/acsnano.9b08714
   PubMed Web of Science ®Google Scholar
• Li Y, Fu R, Duan Z, Zhu C, Fan D. Artificial nonenzymatic antioxidant mxene nanosheet-anchored injectable hydrogel as a mild photothermal-controlled oxygen release platform for diabetic wound healing. ACS Nano. 2022;16(5):7486–7502. doi:10.1021/acsnano.1c10575
   Web of Science ®Google Scholar
• Zhou F, Mei J, Yang S, et al. Modified ZIF-8 nanoparticles attenuate osteoarthritis by reprogramming the metabolic pathway of synovial macrophages. ACS Appl Mater Interfaces. 2020;12(2):2009–2022. doi:10.1021/acsami.9b16327
   PubMed Web of Science ®Google Scholar
• Qiao H, Mei J, Yuan K, et al. Immune-regulating strategy against rheumatoid arthritis by inducing tolerogenic dendritic cells with modified zinc peroxide nanoparticles. J Nanobiotechnology. 2022;20(1):323. doi:10.1186/s12951-022-01536-0
   Web of Science ®Google Scholar
• Tong A, Tong C, Fan J, et al. Prussian blue nano-enzyme-assisted photodynamic therapy effectively eradicates MRSA infection in diabetic mouse skin wounds. Biomater Sci. 2023;11(18):6342–6356. doi:10.1039/D3BM01039B
   Web of Science ®Google Scholar
• Wang S, Zheng H, Zhou L, et al. Nanoenzyme-reinforced injectable hydrogel for healing diabetic wounds infected with multidrug resistant bacteria. Nano Lett. 2020;20(7):5149–5158. doi:10.1021/acs.nanolett.0c01371
   PubMed Web of Science ®Google Scholar
• Ma Y, Xu H, Sun B, et al. pH-responsive oxygen and hydrogen peroxide self-supplying nanosystem for photodynamic and chemodynamic therapy of wound infection. ACS Appl Mater Interfaces. 2021;13(50):59720–59730. doi:10.1021/acsami.1c19681
   PubMed Web of Science ®Google Scholar
• Lim DJ, Skinner D, West JM, et al. In vitro evaluation of a novel oxygen-generating biomaterial for chronic rhinosinusitis therapy. Int Forum Allergy Rhinol. 2022;12(2):181–190. doi:10.1002/alr.22875
   Web of Science ®Google Scholar
• Zhang Q, Inagaki NF, Ito T. Recent advances in micro-sized oxygen carriers inspired by red blood cells. Sci Technol Adv Mater. 2023;24(1):2223050. doi:10.1080/14686996.2023.2223050
   PubMed Web of Science ®Google Scholar
• Wu M, Chen C, Liu Z, Tian J, Zhang W. Regulating the bacterial oxygen microenvironment via a perfluorocarbon-conjugated bacteriochlorin for enhanced photodynamic antibacterial efficacy. Acta Biomater. 2022;142:242–252. doi:10.1016/j.actbio.2022.02.013
   Web of Science ®Google Scholar
• Krafft MP. Alleviating tumor hypoxia with perfluorocarbon-based oxygen carriers. Curr Opin Pharmacol. 2020;53:117–125. doi:10.1016/j.coph.2020.08.010
   Web of Science ®Google Scholar
• Zhou Z, Zhang B, Wang H, et al. Two-stage oxygen delivery for enhanced radiotherapy by perfluorocarbon nanoparticles. Theranostics. 2018;8(18):4898–4911. doi:10.7150/thno.27598
   PubMed Web of Science ®Google Scholar
• Zou J, Zhu J, Yang Z, et al. A phototheranostic strategy to continuously deliver singlet oxygen in the dark and hypoxic tumor microenvironment. Angew Chem Int Ed Engl. 2020;59(23):8833–8838. doi:10.1002/anie.201914384
   Web of Science ®Google Scholar
• Wang W, Wang X, Tao F, et al. Fluorinated hyaluronic acid encapsulated perfluorocarbon nanoparticles as tumor-targeted oxygen carriers to enhance radiotherapy. Mol Pharm. 2022;19(11):3948–3958. doi:10.1021/acs.molpharmaceut.2c00432
   Google Scholar
• Xu CH, Ye PJ, Zhou YC, et al. Cell membrane-camouflaged nanoparticles as drug carriers for cancer therapy. Acta Biomater. 2020;105:1–14. doi:10.1016/j.actbio.2020.01.036
   PubMed Web of Science ®Google Scholar
• Luk BT, Zhang L. Cell membrane-camouflaged nanoparticles for drug delivery. J Control Release. 2015;220(Pt B):600–607. doi:10.1016/j.jconrel.2015.07.019
   PubMed Web of Science ®Google Scholar
• Wu P, Jiang X, Yin S, et al. Biomimetic recombinant of red blood cell membranes for improved photothermal therapy. J Nanobiotechnology. 2021;19(1):213. doi:10.1186/s12951-021-00949-7
   Web of Science ®Google Scholar
• Zhang X, Chen G, Liu Y, et al. Black phosphorus-loaded separable microneedles as responsive oxygen delivery carriers for wound healing. ACS Nano. 2020;14(5):5901–5908. doi:10.1021/acsnano.0c01059
   PubMed Web of Science ®Google Scholar
• Chen L, Yang Z, Liu H. Hemoglobin-based oxygen carriers: where are we now in 2023? Medicina. 2023;59(2):396. doi:10.3390/medicina59020396
   Google Scholar
• Sen Gupta A. Hemoglobin-based oxygen carriers: current state-of-the-art and novel molecules. Shock. 2019;52(1S Suppl 1):70–83. doi:10.1097/SHK.0000000000001009
   Google Scholar
• Bryan N, Ahswin H, Smart N, et al. Reactive oxygen species (ROS)--a family of fate deciding molecules pivotal in constructive inflammation and wound healing. Eur Cell Mater. 2012;24:249–265. doi:10.22203/eCM.v024a18
   Web of Science ®Google Scholar
• Gil D, Rodriguez J, Ward B, et al. Antioxidant activity of SOD and catalase conjugated with nanocrystalline ceria. Bioengineering. 2017;4(1):18. doi:10.3390/bioengineering4010018
   PubMedGoogle Scholar
• Ling Y, Nie D, Huang Y, et al. Antioxidant cascade nanoenzyme antagonize inflammatory pain by modulating MAPK/p-65 signaling pathway. Adv Sci. 2023;10(12):e2206934. doi:10.1002/advs.202206934
   Web of Science ®Google Scholar
• Singh N, NaveenKumar SK, Geethika M, Mugesh G. A cerium vanadate nanozyme with specific superoxide dismutase activity regulates mitochondrial function and ATP synthesis in neuronal cells. Angew Chem Int Ed Engl. 2021;60(6):3121–3130. doi:10.1002/anie.202011711
   Web of Science ®Google Scholar
• Kang JI, Park KM. Oxygen-supplying syringe to create hyperoxia-inducible hydrogels for in situ tissue regeneration. Biomaterials. 2023;293:121943. doi:10.1016/j.biomaterials.2022.121943
   Web of Science ®Google Scholar
• Yan K, Mu C, Zhang C, et al. Pt nanoenzyme decorated yolk-shell nanoplatform as an oxygen generator for enhanced multi-modality imaging-guided phototherapy. J Colloid Interface Sci. 2022;616:759–768. doi:10.1016/j.jcis.2022.02.042
   Web of Science ®Google Scholar
• Zhang DY, Liu H, Rizwan Younis M, et al. Corrigendum to “Ultrasmall platinum nanozymes as broad-spectrum antioxidants for theranostic application in acute kidney injury” [Chem. Eng. J. 409 (2020) 127371]. Chem Eng J. 2021;421(421):129963. doi:10.1016/j.cej.2021.129963
   Google Scholar
• Bardi G, Boselli L, Pompa PP. Anti-inflammatory potential of platinum nanozymes: mechanisms and perspectives. Nanoscale. 2023;15(35):14284–14300. doi:10.1039/D3NR03016D
   Web of Science ®Google Scholar
• Tsuji G, Hashimoto-Hachiya A, Takemura M, et al. Palladium and platinum nanoparticles activate AHR and NRF2 in human keratinocytes-implications in vitiligo therapy. J Invest Dermatol. 2017;137(7):1582–1586. doi:10.1016/j.jid.2017.02.981
   Web of Science ®Google Scholar
• Zhang W, Li S, Liu X, et al. Oxygen-generating MnO2 nanodots-anchored versatile nanoplatform for combined chemo-photodynamic therapy in hypoxic cancer. Adv Funct Mater. 2018;28(13):1706375.
   Web of Science ®Google Scholar
• Mbugua SN, Keramidas A. Targeting tumor microenvironment by metal peroxide nanoparticles in cancer therapy. Bioinorg Chem Appl. 2022;2022:5041399. doi:10.1155/2022/5041399
   Web of Science ®Google Scholar